LIAISON XL MUREX HBsAg Quant - Hepatitis B virus surface antigen IVD, kit, chemiluminescent immunoassay

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Mevcut itibaren:

DiaSorin Australia Pty Ltd

Sınıf:

Class 4

Tarafından üretildi:

DiaSorin Italia SpA Via Crescentino snc, Saluggia VC, 13040 Italy

Terapötik alanı:

48321 - Hepatitis B virus surface antigen IVD, kit, chemiluminescent immunoassay

Terapötik endikasyonlar:

LIAISON? XL MUREX HBsAg Quant assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of hepatitis B surface antigen (HBsAg) in human serum or plasma samples. For the quantitative determination of Hepatitis B surface Antigen (HBsAg) in human serum and plasma samples, including specimens collected up to 24 hours post-mortem (non-heart beating).

Yetkilendirme durumu:

A

Yetkilendirme tarihi:

2013-07-20